Serum Lipase Alone is Sufficient
For evaluating pancreatic disease, order serum lipase alone—not amylase. Lipase is more sensitive, more specific, and remains elevated longer than amylase, making it the superior single test for diagnosing acute pancreatitis 1, 2.
Why Lipase Over Amylase
The evidence strongly favors lipase as the preferred pancreatic enzyme:
- Higher sensitivity: Lipase demonstrates 79-96.6% sensitivity compared to amylase's 62-78.6% 2, 3, 4
- Better specificity: Lipase shows 89-99.4% specificity versus amylase's 93-99.1% 2, 3
- Longer diagnostic window: Lipase remains elevated for 8-14 days (peaks at 24 hours), while amylase normalizes in 3-7 days (peaks at 48 hours) 2. This makes lipase useful for both early and late presentations.
- More pancreas-specific: Amylase is secreted by salivary glands, small intestine, ovaries, adipose tissue, and skeletal muscles, reducing its specificity 2
Guideline Recommendations
The 2007 AGA Institute guidelines state that "elevation of lipase levels is somewhat more specific and is thus preferred" 1. The 2019 WSES guidelines explicitly note that "serum lipase is considered a more reliable diagnostic marker of AP than serum amylase" and that "most current guidelines and recommendations indicate that lipase should be preferred over total and p-amylase" 2.
No Added Value from Dual Testing
Ordering both tests provides minimal additional diagnostic benefit. Studies show that dual testing increases sensitivity by only 1-2% (from 91-96% with lipase alone to 93% with both) 5, 4. This marginal improvement does not justify the additional cost and complexity 5, 3, 6.
Diagnostic Threshold
Use a cut-off of three times the upper limit of normal for diagnosing acute pancreatitis 1, 2. Elevations less than 3× the upper limit have low specificity and are consistent with but not diagnostic of acute pancreatitis 1.
Important Caveats
- Renal failure: Both amylase and lipase are renally eliminated and will be persistently elevated in end-stage renal disease, limiting their diagnostic utility in this population 1, 7
- Non-pancreatic causes: Lipase can be elevated in renal disease, appendicitis, acute cholecystitis, chronic pancreatitis, and bowel obstruction 2
- Severity assessment: Neither enzyme predicts disease severity or etiology—use clinical assessment, APACHE II scoring (cutoff >8), and CT imaging after 72 hours for this purpose 1
Cost Considerations
Eliminating routine amylase testing saves approximately $350,000-$893 annually per institution without compromising diagnostic accuracy 3, 6. The cost difference per test is minimal (£0.69 for single enzyme vs £0.99 for both), but the volume adds up significantly 3.
Practical Implementation
Remove amylase from order sets and computerized order entry systems. Educational interventions alone are insufficient—system-based changes (removing amylase from order forms, decoupling it from lipase in ordering systems) are necessary to change practice patterns effectively 6.